4//SEC Filing
Brennan David R 4
Accession 0000899866-20-000050
CIK 0000899866other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 5:22 PM ET
Size
6.7 KB
Accession
0000899866-20-000050
Insider Transaction Report
Form 4
Brennan David R
Director
Transactions
- Award
Common Stock, par value $.0001 per share
2020-05-14+3,468→ 15,109 total - Award
Common Stock, par value $.0001 per share
2020-05-14+2,428→ 17,537 total
Footnotes (2)
- [F1]Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the earlier of (i) the first anniversary of the grant date and (ii) the date of the 2021 Annual Shareholder Meeting.
- [F2]Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu of the annual cash retainer that the director was entitled to receive for service as a director.
Documents
Issuer
ALEXION PHARMACEUTICALS, INC.
CIK 0000899866
Entity typeother
Related Parties
1- filerCIK 0001609305
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 5:22 PM ET
- Size
- 6.7 KB